Harbour Investments, Inc. Precigen, Inc. Transaction History

Harbour Investments, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 16, 2022	SELL	$3.53 - $5.5 $35 - $55	-10 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$4.99 - $6.55 $9 - $13	-2 Reduced 16.67%	10 $0
Q2 2021 Aug 16, 2021	SELL	$6.24 - $8.22 $6 - $8	-1 Reduced 7.69%	12 $0
Q1 2021 Aug 17, 2021	BUY	$6.74 - $10.95 $80 - $131	12 Added 1200.0%	13 $0
Q1 2021 May 12, 2021	BUY	$6.74 - $10.95 $6 - $10	1 New	1 $0

143

159M

232K

69K

Ticker PGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 208,150,000
Market Cap $179M
Description
Precigen, Inc. discovers and develops the next generation of gene and cellular therapies in the United States. It also provides disease-modifying therapeutics; genetically engineered swine for regenerative medicine applications; and reproductive and embryo transfer technologies. In addition, the company offers UltraVector platform that incorpora...

Get notified when there are updates to the investment portfolio of Harbour Investments, Inc., based on Form 13F filings with the SEC.

Stay updated on Harbour Investments, Inc. with notifications on news.